Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

223 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Thalidomide in combination with dexamethasone for pretreated patients with multiple myeloma: serum level of soluble interleukin-2 receptor as a predictive factor for response rate and for survival.
Schütt P, Ebeling P, Buttkereit U, Brandhorst D, Opalka B, Poser M, Müller S, Flasshove M, Moritz T, Seeber S, Nowrousian MR. Schütt P, et al. Among authors: brandhorst d. Ann Hematol. 2005 Sep;84(9):594-600. doi: 10.1007/s00277-005-1007-7. Epub 2005 Mar 3. Ann Hematol. 2005. PMID: 15744524 Clinical Trial.
In vitro dendritic cell generation and lymphocyte subsets in myeloma patients: influence of thalidomide and high-dose chemotherapy treatment.
Schütt P, Buttkereit U, Brandhorst D, Lindemann M, Schmiedl S, Grosse-Wilde H, Seeber S, Nowrousian MR, Opalka B, Moritz T. Schütt P, et al. Among authors: brandhorst d. Cancer Immunol Immunother. 2005 May;54(5):506-12. doi: 10.1007/s00262-004-0633-6. Epub 2004 Nov 20. Cancer Immunol Immunother. 2005. PMID: 15750834
Serum free light chain analysis and urine immunofixation electrophoresis in patients with multiple myeloma.
Nowrousian MR, Brandhorst D, Sammet C, Kellert M, Daniels R, Schuett P, Poser M, Mueller S, Ebeling P, Welt A, Bradwell AR, Buttkereit U, Opalka B, Flasshove M, Moritz T, Seeber S. Nowrousian MR, et al. Among authors: brandhorst d. Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8706-14. doi: 10.1158/1078-0432.CCR-05-0486. Clin Cancer Res. 2005. PMID: 16361557
Thalidomide in combination with vincristine, epirubicin and dexamethasone (VED) for previously untreated patients with multiple myeloma.
Schütt P, Ebeling P, Buttkereit U, Brandhorst D, Opalka B, Hoiczyk M, Flasshove M, Hense J, Bojko P, Metz K, Moritz T, Seeber S, Nowrousian MR. Schütt P, et al. Among authors: brandhorst d. Eur J Haematol. 2005 Jan;74(1):40-6. doi: 10.1111/j.1600-0609.2004.00349.x. Eur J Haematol. 2005. PMID: 15613105 Clinical Trial.
223 results